BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 128684)

  • 21. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
    Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of hirsutism and acne. Sequential inverse therapy with anti-androgen-estrogen].
    Lebeau M; Vokaer R
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(7):715-21. PubMed ID: 4267704
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of anti-androgens in skin diseases].
    Nolting S
    Z Hautkr; 1979 Jun; 54(12):529-32. PubMed ID: 88827
    [No Abstract]   [Full Text] [Related]  

  • 24. [A new ovulation inhibitor antiandrogen].
    Millet-part A; Blanes-espi A; Ferrer-barriendos J; Siqueira L; Acosta E
    J Bras Ginecol; 1984 Mar; 94(3):91-7. PubMed ID: 12266391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of acne, hirsutism and alopecia, by cyproterone acetate and ethinyl estradiol].
    Neale C; Krebs D; Bettendorf G
    Acta Endocrinol Suppl (Copenh); 1971; 152():13. PubMed ID: 4251532
    [No Abstract]   [Full Text] [Related]  

  • 26. [Differentiated application of oral contraceptives basing on the different side effects of synthetic progestins (author's transl)].
    Braendle W; Leidenberger F
    Ther Umsch; 1976 Apr; 33(4):231-3. PubMed ID: 137547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy of androgenetic sympatomatology with cyproterone acetate and ethinyl estradiol.
    Schindler AE; Mangold K; Friedrich E; Keller E; Göser R
    Arch Gynakol; 1978 May; 225(2):103-7. PubMed ID: 148876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hirsutism, acne and alopecia with cyproterone acetate.
    Ekoe JM; Burckhardt P; Ruedi B
    Dermatologica; 1980; 160(6):398-404. PubMed ID: 6446466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism.
    Hammerstein J; Meckies J; Leo-Rossberg I; Moltz L; Zielske F
    J Steroid Biochem; 1975 Jun; 6(6):827-36. PubMed ID: 126335
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antiandrogen treatment with cyproterone acetate in with virilizing symptoms].
    Abrahamsson L; Hackl H; Lindström B; Martinik J
    Lakartidningen; 1981 Nov; 78(47):4259-61. PubMed ID: 6460145
    [No Abstract]   [Full Text] [Related]  

  • 32. [Medium-dose oral cyproterone acetate therapy in women with moderate androgenization. Results of a multicenter double-blind study].
    Moltz L; Kaiser E
    Geburtshilfe Frauenheilkd; 1984 Jan; 44(1):47-52. PubMed ID: 6230282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Indications and limits of anti-androgen therapy].
    Zaun H
    Z Hautkr; 1984 Aug; 59(16):1090-7. PubMed ID: 6207673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect and side-effect of cyproteron-acetat-treatment (author's transl)].
    Braendle W; Boess H; Breckwoldt M; Leven C; Bettendorf G
    Arch Gynakol; 1974 Jul; 216(4):335-45. PubMed ID: 4277171
    [No Abstract]   [Full Text] [Related]  

  • 35. [Long-term treatment of virilized women with cyproterone acetate (author's transl)].
    Abrahamsson L; Hackl H; Lindström B; Sogn J
    Wien Klin Wochenschr; 1981 Sep; 93(17):552-6. PubMed ID: 6458162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormonotherapy in acute, idiopathic hirsutism, and seborrheic alopecia (author's transl)].
    Belaube P; Devaux J; Gamby T; Garcin G; Privat Y
    Sem Hop; 1982 Jul; 58(26-27):1650-3. PubMed ID: 6287643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Evaluation of the clinical effect].
    Pedersen IM; Nielsen DR; Larsen J; Starup J
    Ugeskr Laeger; 1985 Aug; 147(33):2594-6. PubMed ID: 2933858
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial.
    Plewig G; Cunliffe WJ; Binder N; Höschen K
    Contraception; 2009 Jul; 80(1):25-33. PubMed ID: 19501212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of androgenization symptoms: double blind study of an antiandrogen preparation (SH B 209 AB) against neogynon (author's transl)].
    Lachnit-Fixson U; Kaufmann J
    Med Klin; 1977 Nov; 72(45):1922-6. PubMed ID: 144842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of cyproterone acetate in the treatment of acne].
    Piquero Martín J; Acosta H
    Med Cutan Ibero Lat Am; 1982; 10(4):261-6. PubMed ID: 6222232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.